Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity

Journal of Cellular Biochemistry

Volumn 104, Issue 5, 2008, Pages 1853-1864

  Liao, Qing Chuan ^a   Li, Ya Lin ^b   Qin, Yan Fang ^c   Quarles, L Darryl ^d   Xu, Kang Kang ^a   Li, Rong ^a   Zhou, Hong Hao ^b   Xiao, Zhou Sheng ^b,d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Adipogenic differentiation; Extracellular signal regulated kinases 1 and 2 (ERK1 2); Genistein; Mesenchymal stem cell

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; FIBROBLAST GROWTH FACTOR 2; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHYTOESTROGEN; PROTEIN P2;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INCUBATION TIME; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENISTEIN; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PHYTOESTROGENS; PPAR GAMMA; PROTEIN BINDING; PROTEIN KINASE INHIBITORS;

ATTHIS;

EID: 50249160525     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21753     Document Type: Article

References (33)

1. Ahdjoudj S, Fromigué O, Marie PJ. 2004. Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: Potential implication in the treatment of age-related bone loss. Histol Histopathol 19:151-157.
2. Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y, Binetury B. 2002. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361:621-627.
3. Bost F, Aouadi M, Caron L, Binétruy B. 2005. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87:51-56.
4. Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW. 2002. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 17:394-405.
5. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Löwik CW. 2003. Peroxisome proliferator-activated receptor γ(PPARγ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278:962-967.
6. Font de Mora J, Porras A, Ahn N, Santos E. 1997. Mitogenactivated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol Cell Biol 17:6068-6075.
7. Frey RS, Singletary KW. 2003. Genistein activates p38 mitogen-activated protein kinase, inactivates ERK1/ ERK2 and decreases Cdc25C expression in immortalized human mammary epithelial cells. J Nutr 133:226-231.
8. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. 1997. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82:414-417.
9. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I. 2004. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 145: 848-859.
10. Hu E, Kim JB, Sarraf P, Spiegelman BM. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARy. Science 274:2100-2103.
11. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S. 1999. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140:1893-1900.
12. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, Takeda A, Ikegami S. 2000. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Commun 274:697-701.
13. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. 2001. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171.
14. Kim KA, Kim JH, Wang Y, Sul HS. 2007. Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 27:2294-2308.
15. Liao QC, Xiao ZS, Qin YP, Zhou HH. 2007. Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfal pathway in bone marrow culture. Acta Pharmacol Sin 28:1597-1602.
16. Linford NJ, Yang Y, Cook DG, Dorsa DM. 2001. Neuronal apoptosis resulting from high dose of isofiavone genistein: Role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 299:67-75.
17. Loftus TM, Lane MD. 1997. Modulating the transcriptional control of adipogenesis. Curr Opin Genet Dev 7:603-608.
18. Machinal-Quélin F, Dieudonné MN, Leneveu MC, Pecquery R, Giudicelli Y. 2002. Proadipogenic effect of leptin on rat preadipocytes in vitro: Activation of MAPK and STAT3 signaling pathways. Am J Physiol Cell Physiol 282:C853-C863.
19. Milasincic DJ, Calera MR, Farmer SR, Pilch PF. 1996. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol 16:5964-5973.
20. Nuttall ME, Gimble JM. 2000. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184.
21. Nuttall ME, Gimble JM. 2004. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4:290-294.
22. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y, Matsumoto T. 2002. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) α or β. Endocrinology 143:2349-2356.
23. Pan W, Quarles LD, Song LH, Yu YH, Jiao C, Tang HB, Jiang CH, Deng HW, Li YJ, Zhou HH, Xiao ZS. 2005. Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J Cell Biochem 94: 307-316.
24. Park BH, Qiang L, Farmer SR. 2004. Phosphorylation of C/ EBPβ at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 24:8671-8680.
25. Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. 2003. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors a and β. J Cell Biochem 89:633-646.
26. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. 2000. Transcriptional regulation of adipogenesis. Genes Dev 14:1293-1307.
27. Sakaue H, Ogawa W, Nakamura T, Mori T, Nakamura K, Kasuga M. 2004. Role of MAPK Phosphatase-1 (MKP-1) in adipocyte differentiation. J Biol Chem 279:39951-39957.
28. Shimba S, Wada T, Tezuka M. 2001. Arylhydrocarbon receptor (AhR) is involved in negative regulation of adipose differentiation in 3T3-L1 cells: AhR inhibits adipose differentiation independently of dioxin. J Cell Sci 114:2809-2817.
29. Szkudelska K, Nogowski L, Szkudelski T. 2000. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 75:265-271.
30. Tanabe Y, Koga M, Saito M, Matsunaga Y, Nakayama K. 2004. Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARγ2. J Cell Sci 117:3605-3614.
31. Tang QQ, Gronborg M, Huang H, Kim JW, Otto TC, Pandey A, Lane MD. 2005. Sequential phosphorylation of CCAAT enhancer-binding protein β by MAPK and glycogen synthase kinase 3β is required for adipogenesis. Proc Natl Acda Sci USA 102:9766-9771.
32. Wang X, Clubbs EA, Bomser JA. 2006. Genistein modulates prostate epithelial cell proliferation via estrogen-and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem 17:204-210.
33. Weyman CM, Wolfman A. 1998. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 139: 1794-1800.